Amylin Pharmaceuticals, Inc. and Takeda Pharmaceutical Company Limited announced that following positive phase 2 study results in a new obesity treatment, they will  advance towards phase 3 development of a combination treatment for obesity which includes pramlintide (an analog of the natural hormone amylin)  and metreleptin  (an...

A new study conducted at the Chinese Academy of Sciences in Shanghai found that young children may be more apt to have high blood sugar, a precursor to diabetes, if they average 8 hours or less of sleep a night, Reuters reported The team headed by Dr. Zhijie Yu investigated sleep duration and blood sugar levels in 619 obese and 617 non-obese...

Breastfeeding her child may lower a woman’s risk of developing Metabolic Syndrome, a condition linked to heart disease and diabetes in women, according to a Kaiser Permanente study that was published online by PR Newswire, and will appear in the February issue of Diabetes. Breastfeeding lowers Metabolic Syndrome risk by 39 to 56...

Compugen Ltd. announced today the discovery and experimental confirmation of a genetic marker for type 2 diabetes.  A predisposition marker is of particular value in type 2 diabetes since lifestyle plays an important role in the disease.  Following diagnosis, those at high-risk might benefit from more aggressive management either through...

Pre-diabetes is a condition in which people have higher than normal blood sugar levels.  BBC News reports a person with pre-diabetes has a 12 times increased risk of developing full-blown diabetes.  The charity, Diabetes UK, called the condition a “ticking time bomb.” Pre-diabetes often occurs in people who are overweight,...